Table 1.
Vmax, Km, and kcat Values for Incorporations of TTP and AZTTP, dCTP and ddCP, or dATP and EFdATP by HIV-1 RT at 6 and 0.25 mM Mg2+
conditiona | [RT] (nM) | Vmax (nM/min) | kcatb (min−1) | Km (μM) | kcat/Kmc (x-fold decrease) | p valued |
---|---|---|---|---|---|---|
6 mM Mg2+ dTTP | 0.8 | 1.1 ± 0.1 | 1.3 ± 0.09 | 2.3 ± 0.2 | 0.57 | – |
0.25 mM Mg2+ dTTP | 0.8 | 0.65 ± 0.07 | 0.81 ± 0.09 | 5.7 ± 0.7 | 0.14 (4.1) | <0.001 |
6 mM Mg2+ AZTTP | 0.8 | 0.95 ± 0.08 | 1.2 ± 0.09 | 2.3 ± 0.4 | 0.52 | – |
0.25 mM Mg2+ AZTTP | 0.8 | 0.26 ± 0.01 | 0.32 ± 0.01 | 12 ± 1 | 0.027 (19) | <0.001 |
6 mM Mg2+ dCTP | 2 | 2.1 ± 0.1 | 1.0 ± 0.1 | 1.3 ± 0.4 | 0.77 | – |
0.25 mM Mg2+ dCTP | 2 | 1.4 ± 0.1 | 0.68 ± 0.03 | 3.9 ± 1.7 | 0.17 (4.5) | 0.05 |
6 mM Mg2+ ddCTP | 0.5 | 1.4 ± 0.2 | 0.72 ± 0.08 | 5.0 ± 0.3 | 0.14 | – |
0.25 mM Mg2+ ddCTP | 0.5 | 0.23 ± 0.05 | 0.12 ± 0.03 | 12.5 ± 3.5 | 0.01 (18) | <0.001 |
6 mM Mg2+ dATP | 0.8 | 2.1 ± 0.2 | 2.6 ± 0.3 | 2.2 ± 0.8 | 1.2 | – |
0.25 mM Mg2+ dATP | 0.8 | 0.72 ± 0.08 | 0.90 ± 0.09 | 2.5 ± 1.1 | 0.36 (3.3) | 0.1 |
6 mM Mg2+ EFdATP | 0.8 | 0.72 ± 0.02 | 0.90 ± 0.01 | 1.1 ± 0.1 | 0.82 | – |
0.25 mM Mg2+ EFdATP | 0.8 | 0.53 ± 0.27 | 0.66 ± 0.35 | 3.5 ± 2.2 | 0.19 (4.3) | 0.1 |
Assays were conducted with a 20-nucleotide template and a 19-nucleotide 5′ end-labeled primer as described previously.37 The single template-directed nucleotide was a T opposite an A, a C opposite a G, or an A opposite a T for AZT, ddCTP, or EFdATP, respectively. All assays used 0.8 nM RT. Results are averages of three experiments ± SD.
kcat was calculated by dividing Vmax by the enzyme concentration (0.8 nM).
The x-fold decrease in enzyme efficiency (as judged by kcat/Km) compared to the 6 mM result (number above) with the same nucleotide or inhibitor.
p values were calculated using a standard Student’s t test for kcat/Km values between 0.25 and 6 mM Mg2+.